- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
NXTMH
HEL
Week ended 07 Aug 2026
Weekly Investor Report
Nexstim Plc · Healthcare · Medical Devices
Latest close
9.59 EUR
1.1%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -3.6% below the Trend Line and sits at 19.9% of its 52-week range. The latest completed week returned 1.1%, after a -2.3% four-week move. The latest news-sentiment score is 50/100.
Setup score
31
out of 100
Latest Close
9.59 EUR
7 Aug 2026
1W Return
1.1%
latest completed week
4W Return
-2.3%
short-term follow-through
12W Return
4.7%
quarterly tape
Trend Breadth
40.4%
21 of 52 weeks active
Volume Ratio
1.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Next-week expectancy is negative at 36.47% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.1%
Latest completed week; four-week move -2.3%.
Indicator stack
22/68
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 36.47%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
4 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -3.6% below the Trend Line and sits at 19.9% of its 52-week range. The latest completed week returned 1.1%, after a -2.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2212-week average 0.12
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.22Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -2.3% over four weeks, 4.7% over 12 weeks, and -33.4% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year21
Trend breadth40.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.87Latest activity-pressure read.
Pressure change35.2%Four-week change in activity pressure.
Leadership-25.35Latest relative-leadership reading.
RS change3.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 4 relevant articles.
0 positive · 4 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-41.7%Distance below the 52-week high.
13-week volatility3.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2614 weeks finished lower.
Best week+15.5%Week of 8 May.
Worst week-17.4%Week of 6 Mar.
Latest week+1.1%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains8
Flat weeks1
Modest losses8
Sharp losses6
Recent vol3.9%13-week weekly-return volatility.
Base vol5.5%52-week weekly-return volatility.
Up/down split20/30Count of positive and negative weeks in the 52-week window.
Average skew4.3% / -3.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFI Healthcare
4-week rank12 / 16
Group average1.5%
Trend breadth18.8%
Trend18.8%active weekly trend signals
MD68.8%positive activity pressure
RS18.8%positive relative leadership
Four-week leaders
IndustryFI Medical Devices
4-week rank5 / 5
Group average2.7%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD60.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape29/100
Trend, activity pressure, participation, and risk combine to a 29/100 tape read.
Indicator analysis28/100Latest 12-week confirmation: trend 0/12, activity pressure 9/12, relative leadership 0/12.
Activity pressure 0.22; No reversal markers Next-Week ExpectancyNegative 36.47%Next-week expectancy is negative with a 36.47% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 4 relevant articles.
Nexstim : Finnish Private Clinic Group Orders Additional Nexstim NBS 6 System Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 9.59 EUR | 1.1% | 9.95 EUR | 7.38 EUR | 0.87 | -25.35 | 35.5K | Off |
| 31 Jul 2026 | 9.49 EUR | -3.7% | 10.08 EUR | 7.34 EUR | 0.93 | -26.86 | 45.3K | Off |
| 24 Jul 2026 | 9.85 EUR | -2.3% | 10.23 EUR | 7.30 EUR | 0.90 | -24.85 | 30.8K | Off |
| 17 Jul 2026 | 10.08 EUR | 2.6% | 10.36 EUR | 7.26 EUR | 0.82 | -23.61 | 125.0K | Off |
| 10 Jul 2026 | 9.82 EUR | -0.1% | 10.50 EUR | 7.22 EUR | 0.64 | -26.38 | 35.2K | Off |
| 3 Jul 2026 | 9.83 EUR | 0.5% | 10.64 EUR | 7.18 EUR | 0.49 | -28.28 | 908 | Off |
| 26 Jun 2026 | 9.78 EUR | -1.6% | 10.79 EUR | 7.14 EUR | 0.38 | -28.12 | 3.9K | Off |
| 19 Jun 2026 | 9.94 EUR | -0.6% | 10.96 EUR | 7.10 EUR | 0.26 | -28.71 | 10.6K | Off |
| 12 Jun 2026 | 10.00 EUR | 11.1% | 11.11 EUR | 7.06 EUR | 0.09 | -29.76 | 5.6K | Off |
| 5 Jun 2026 | 9.00 EUR | 2.9% | 11.25 EUR | 7.01 EUR | -0.10 | -38.36 | 1.5K | Off |
| 29 May 2026 | 8.75 EUR | 0.8% | 11.45 EUR | 6.98 EUR | -0.24 | -40.25 | 21.3K | Off |
| 22 May 2026 | 8.68 EUR | -5.2% | 11.64 EUR | 6.95 EUR | -0.58 | -41.09 | 22.3K | Off |
| 15 May 2026 | 9.16 EUR | -2.6% | 11.81 EUR | 6.91 EUR | -0.83 | -35.85 | 21.3K | Off |
| 8 May 2026 | 9.40 EUR | 15.5% | 12.01 EUR | 6.88 EUR | -1.10 | -33.91 | 25.3K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.